Parkinson's Disease Trial, By Invitation NCT07548801 Sponsor: Université Libre de Bruxelles Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT07548801
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have mild to moderate Parkinson's disease, based on standard medical scoring (confirm with trial site for specific score details)
  • People who are older than 18 years of age
  • People who have signed a written consent form agreeing to take part

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are pregnant
  • People who are 18 years of age or younger
  • People who have metal implants inside their skull, such as surgical clips or orthopaedic hardware
  • People who have an implanted electronic device, such as a pacemaker, cochlear implant, or deep brain stimulator
  • People with a history of epileptic seizures
  • People who have or have had a neurological condition affecting arm and hand control (such as stroke, a brain or nerve tumour, or a degenerative disease), or a nerve, muscle, or joint condition that affects the movement of the upper limbs
  • People who are unable to understand or carry out the physical tasks required by the trial
  • People who regularly take multiple medications that affect mood or brain function, such as antipsychotics, anti-epileptic drugs, or benzodiazepines

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Université Libre de Bruxelles
Registry
ClinicalTrials.gov
Start date
24 September 2025
Est. completion
1 November 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

MDS-UPDRS (Unit on a scale); CCAS (Unit on a scale)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov